newsfilter
← Latest News
GlobeNewswire·

Galera Reports Third Quarter 2021 Financial Results and Recent Corporate Updates

Recently announced topline results of Phase 3 ROMAN trial of avasopasem for radiotherapy-induced severe oral mucositis Enrollment ongoing in GRECO-1 and GRECO-2 trials of rucosopasem (GC4711) in combination with SBRT in patients with NSCLC and pancrea